TI
tru Independence Portfolio holdings
AUM
$346M
1-Year Return
13.72%
This Quarter Return
+7.04%
1 Year Return
+13.72%
3 Year Return
+42.26%
5 Year Return
+64.25%
10 Year Return
–
AUM
$353M
AUM Growth
+$352M
(+50,931%)
Cap. Flow
-$152M
Cap. Flow
% of AUM
-43.02%
Top 10 Holdings %
Top 10 Hldgs %
21.3%
Holding
978
New
70
Increased
46
Reduced
164
Closed
661
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$11.7M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$7.58M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$6.99M |
| 4 |
SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$6.71M |
| 5 |
Schwab Intermediately-Term US Treasury ETF
SCHR
|
+$5.76M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.6M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$56.1M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$33.7M |
| 4 |
SPDR Gold Trust
GLD
|
+$10.4M |
| 5 |
Apple
AAPL
|
+$8.4M |
Sector Composition
| 1 | Technology | 9.56% |
| 2 | Financials | 9.1% |
| 3 | Industrials | 9.08% |
| 4 | Healthcare | 8.91% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
S&P Global
SPGI
$166B
| $11K | ﹤0.01% |
31
| – | – |
|
277
iShares Biotechnology ETF
IBB
$5.69B
| $10K | ﹤0.01% |
+77
| New | +$10K |
|
278
Eli Lilly
LLY
$676B
| $10K | ﹤0.01% |
65
-43
| -40% | -$6.62K |
|
279
Phillips 66
PSX
$53.4B
| $10K | ﹤0.01% |
200
-2,042
| -91% | -$102K |
|
280
iShares MSCI Israel ETF
EIS
$411M
| $10K | ﹤0.01% |
+200
| New | +$10K |
|
281
Expedia Group
EXPE
$26.8B
| $10K | ﹤0.01% |
111
-2,903
| -96% | -$262K |
|
282
iShares Russell Mid-Cap Growth ETF
IWP
$20.6B
| $9K | ﹤0.01% |
+102
| New | +$9K |
|
283
Lam Research
LRCX
$142B
| $9K | ﹤0.01% |
280
| – | – |
|
284
MSC Industrial Direct
MSM
$5.09B
| $9K | ﹤0.01% |
135
| – | – |
|
285
Schlumberger
SLB
$54.1B
| $9K | ﹤0.01% |
520
-47,698
| -99% | -$826K |
|
286
CME Group
CME
$93.8B
| $8K | ﹤0.01% |
45
-537
| -92% | -$95.5K |
|
287
F5
FFIV
$18.8B
| $8K | ﹤0.01% |
65
-300
| -82% | -$36.9K |
|
288
Parker-Hannifin
PH
$97.2B
| $8K | ﹤0.01% |
40
| – | – |
|
289
Alaska Air
ALK
$7.2B
| $7K | ﹤0.01% |
200
| – | – |
|
290
NVIDIA
NVDA
$4.34T
| $7K | ﹤0.01% |
520
-4,200
| -89% | -$56.5K |
|
291
Sempra
SRE
$53.7B
| $7K | ﹤0.01% |
110
| – | – |
|
|
292
Bristol-Myers Squibb
BMY
$96.9B
| $6K | ﹤0.01% |
100
-1,027,472
| -100% | -$61.6M |
|
293
Chubb
CB
$111B
| $6K | ﹤0.01% |
51
-3,400
| -99% | -$400K |
|
294
Carnival Corp
CCL
$43.4B
| $6K | ﹤0.01% |
420
-2,299
| -85% | -$32.8K |
|
295
Goldman Sachs
GS
$235B
| $6K | ﹤0.01% |
28
-375
| -93% | -$80.4K |
|
296
KB Financial Group
KB
$30.8B
| $6K | ﹤0.01% |
185
| – | – |
|
297
WEC Energy
WEC
$35.1B
| $6K | ﹤0.01% |
59
-363
| -86% | -$36.9K |
|
298
Eaton
ETN
$141B
| $5K | ﹤0.01% |
48
-27
| -36% | -$2.81K |
|
299
Regeneron Pharmaceuticals
REGN
$59.2B
| $5K | ﹤0.01% |
9
-15
| -63% | -$8.33K |
|
300
Yum! Brands
YUM
$40.9B
| $5K | ﹤0.01% |
50
-52
| -51% | -$5.2K |
|